FAIR Act aims to improve rare disease clinical trial, treatment access

(BPT) - Teresa Barnes knows on a deeply personal level the impact that a devastating rare disease can have on a family. Over the course of 10 years, she watched her father, aunt and three uncles die from an incurable lung disease called idiopathic pulmonary fibrosis.

IPF causes irreversible loss of lung function and impacts approximately 150,000 people in the United States. For patients, the lack of effective treatment options makes the need for new therapies especially urgent.

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.

Post a comment
Stop watching this discussion.